The Women's Health Initiative postmenopausal hormone trials: Overview and baseline characteristics of participants

Annals of Epidemiology

Volumn 13, Issue 9 SUPPL., 2003, Pages

  Stefanick, Marcia L ^a   Cochrane, Barbara B ^b,g   Hsia, Judith ^c   Barad, David H ^d   Liu, James H ^e   Johnson, Susan R ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g Cancer Prevention Research Program   (United States)

Author keywords

Breast Cancer; Coronary Heart Disease; Disease Prevention; Estrogen; Hormone Replacement Therapy; Osteoporosis; Postmenopausal Women; Progestin; Randomized Clinical Trial; Women's Health

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; AMENORRHEA; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; BONE MINERAL; BREAST CANCER; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; GALLBLADDER DISEASE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INFORMATION PROCESSING; INFORMED CONSENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MULTICENTER STUDY; OSTEOPENIA; PATIENT SELECTION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCREENING; TREATMENT OUTCOME;

EID: 0142248517     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(03)00045-0     Document Type: Article

References (29)

1. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 19:1998;61-109.
2. American College of Obstetrics and Gynecology. Hormone Replacement Therapy. ACOG Educational Bulletin. 247:1998;498-507.
3. Schairer C., Lubin J., Troisi R., Stergeon S., Brinton L., Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 283:2000;485-491.
4. Ross R.K., Paganini-Hill A., Wan P.C., Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 92:2000;328-332.
5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 273:1995;199-208.
6. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
7. Herrington D.M., Reboussin D.M., Brosnihan B., Sharp P.C., Shumaker S.A., Snyder T.E., et al. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl J Med. 343:2000;522-529.
8. Viscoli C.M., Brass L.M., Kernan W.N., Sarrel P.M., Suissa S., Horwitz R.I. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 345:2001;1243-1249.
9. Col N.F., Pauker S.G., Goldberg R.H., Eckman M.H., Orr R.K., Ross E.M., et al. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med. 159:1999;1458-1466.
10. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series 843. 1994;WHO, Geneva.
11. US Census Bureau. Current Population Reports. 1999;US Government Printing Office, Washington, D.C.
12. National Center for Health Statistics. Health, United States, 1994. 1995;Public Health Service, Hyattsville, MD.
13. Brett K.M., March J.V.R., Madans J.H. Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. J Womens Health. 6:1997;309-316.
14. Lepine L.A., Hillis S.D., Marchbanks P.A., Koonin L.M., Morrow B., Kieke B.A., Wilcox L.S. Hysterectomy surveillance - United States, 1980-1993. Morbidity and Mortality Weekly Report. 46:(SS4):1997;1-15.
15. Lewis D.E., Groff J.Y., Herman C.J., McKeown R.E., Wilcox L.S. Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy. J Womens Health Gend Based Med. 9:(2):2000;S5-S14.
16. US Department of Health and Human Services. Physical Activity and Health: a report of the Surgeon General. 1996;US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA.
17. US Department of Agriculture. Agricultural Research Service. 1994-96 Continuing Survey of Food Intakes by Individuals and 1994-96 Diet and Health Knowledge Survey. US Department of Agriculture (CD-ROM); 1998.
18. Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. 1997;National Academy Press, Washington DC.
19. Anonymous. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 17:(1):2000;1-45.
20. Nieto F.J., Alonso J., Chambless L.E., Zhong M., Ceraso M., Romm F.J., et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities Study. Arch Intern Med. 155:1995;677-684.
21. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M., et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 25:(3):1995;305-313.
22. Kenny S.J., Aubert R.E., Geiss L.S. Prevalence and incidence of non-insulin-dependent diabetes. National Diabetes Data Group. Diabetes in America. 1995;47-68 NIDDKD, Bethesda, MD. (NIH Publication no. 95-1468).
23. Sempos C.T., Cleeman J.I., Carroll M.D., Johnson C.L., Bachorik P.S., Gordon D.J., et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 269:1993;3009-3014.
24. Department of Health and Human Services. National Center for Health Statistics (NCHS). NHANES III (National Health and Nutrition Examination Survey, 1988-1994), CD-ROM (PB97-502959INC). 1997;National Technical Information Service, Springfield, VA.
25. Sightler S.E., Boike G.M., Estape R.E., Averette H.E. Ovarian cancer in women with prior hysterectomy; a 14-year experience at the University of Miami. Obstet Gynecol. 78:1991;681-684.
26. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N Engl J Med. 316:1987;1105-1110.
27. Kritz-Silverstein D., Barrett-Connor E., Wingard D.L. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health. 87:1997;676-680.
28. Miller V.T., Byington R.L., Espeland M.A., Langer R., Marcus R., Shumaker S., et al. Baseline characteristics of the PEPI participants. Control Clin Trials. 16:1995;54S-65S.
29. Grady D., Applegate W., Bush T., Furberg C., Riggs B., Hulley S.B. Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics. Control Clin Trials. 19:1998;314-335.